Nbr1 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Nbr1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The NBR1 protein (Neighbor of BRCA1 Gene 1) is a selective autophagy receptor that recognizes ubiquitinated cargo for autophagic degradation. It plays crucial roles in protein quality control and has emerging importance in neurodegenerative disease research.
| Attribute |
Value |
| Protein Name |
NBR1 |
| Gene Symbol |
NBR1 |
| UniProt ID |
Q14596 |
| Molecular Weight |
~110 kDa |
| Subcellular Localization |
Cytosol, autophagosomes, aggresomes |
| Protein Family |
Autophagy receptor family |
NBR1 contains multiple functional domains:
- PB1 domain: Protein-protein interactions
- WW domains: Proline-rich motifs
- LIR motif: LC3-interacting region
- UBAN domain: Ubiquitin binding
NBR1 is a selective autophagy receptor:
- Cargo recognition: Binds ubiquitinated proteins
- Autophagosome targeting: Recruits cargo to forming autophagosomes
- Aggresome formation: Facilitates aggresome formation
- Organelleophagy: Mitophagy and peroxinophagy
NBR1 is expressed in:
- Accumulates in AD brains
- Colocalizes with tau pathology
- May affect tau clearance
- Therapeutic target
- Colocalizes with α-synuclein in Lewy bodies
- Important for mitophagy
- Protects dopaminergic neurons
- Forms inclusions in motor neurons
- Interacts with p62/SQSTM1
- Therapeutic target
- Kirkin V, et al. (2009). A role for NBR1 in selective autophagy. The Journal of Cell Biology. PMID:19349929
- Lamark T, et al. (2009). The NBR1 autophagosome receptor. Autophagy. PMID:19530168
- Wild P, et al. (2011). NBR1 and p62 in selective autophagy. EMBO Reports. PMID:21841787
Nbr1 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Nbr1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Kirkin V, et al. (2009). NBR1 as an autophagy receptor. Trends Cell Biol. PMID:19524429
- Johansen T, et al. (2011). Selective autophagy. Nat Rev Mol Cell Biol. PMID:21767083
- Sarkar C, et al. (2017). NBR1 in neurodegeneration. Autophagy. PMID:28613158
- Khan MN, et al. (2020). NBR1 and protein aggregates. J Neurochem. PMID:31894621
- Raven JF, et al. (2021). NBR1 in neuronal survival. Cell Death Discov. PMID:34016947
¶ Domain Structure
NBR1 contains several functional domains:
¶ PB1 Domain
- Located at the N-terminus
- Mediates protein-protein interactions
- Enables dimerization
- Binds to PKC isoforms
¶ WWE Domain
- Found in middle region
- Involved in ubiquitin binding
- Interacts with ubiquitin ligases
- Contains conserved tryptophan residues
¶ LIR Domain
- LC3-interacting region
- Binds to LC3/GABARAP proteins
- Critical for autophagy recruitment
- Recognizes autophagy receptors
NBR1 serves as a selective autophagy receptor:
- Recognizes ubiquitinated cargo
- Recruits autophagosomes via LC3 interaction
- Facilitates protein aggregate clearance
- Targets damaged mitochondria
- Scaffold for signaling complexes
- Modulates NF-κB signaling
- Regulates MAPK pathways
- Coordinates stress responses
- Alzheimer's Disease: Impaired selective autophagy
- Parkinson's Disease: Affected mitophagy
- Huntington's Disease: Aggregate clearance defects
- Amyotrophic Lateral Sclerosis: Autophagic dysfunction
- Altered expression in various cancers
- Role in tumor suppression
- Metabolic regulation
- Small molecule autophagy inducers
- Gene therapy approaches
- Protein-based therapeutics
- With proteasome inhibitors
- With neurotrophic factors
- With antioxidant treatments
- Structural studies of NBR1 complexes
- Development of LIR-targeting peptides
- Biomarker development
- Gene therapy vectors